These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 6477542)
1. The development of wearable-type artificial endocrine pancreas and its usefulness in glycaemic control of human diabetes mellitus. Shichiri M; Kawamori R; Hakui N; Asakawa N; Yamasaki Y; Abe H Biomed Biochim Acta; 1984; 43(5):561-8. PubMed ID: 6477542 [TBL] [Abstract][Full Text] [Related]
2. Closed-loop glycemic control with a wearable artificial endocrine pancreas. Variations in daily insulin requirements to glycemic response. Shichiri M; Kawamori R; Hakui N; Yamasaki Y; Abe H Diabetes; 1984 Dec; 33(12):1200-2. PubMed ID: 6389235 [TBL] [Abstract][Full Text] [Related]
3. Long-term application of wearable artificial endocrine pancreas--closed-loop intravenous vs subcutaneous insulin infusion. Shichiri M; Kawamori R; Goriya Y; Yamasaki Y; Nomura M; Asakawa N; Kubota M; Kamada T Life Support Syst; 1985; 3 Suppl 1():583-7. PubMed ID: 3916624 [TBL] [Abstract][Full Text] [Related]
4. Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas. Shimoda S; Nishida K; Sakakida M; Konno Y; Ichinose K; Uehara M; Nowak T; Shichiri M Front Med Biol Eng; 1997; 8(3):197-211. PubMed ID: 9444512 [TBL] [Abstract][Full Text] [Related]
5. Experience with an implantable glucose sensor as a prerequisite of an artificial beta cell. Abel P; Müller A; Fischer U Biomed Biochim Acta; 1984; 43(5):577-84. PubMed ID: 6477543 [TBL] [Abstract][Full Text] [Related]
6. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903 [TBL] [Abstract][Full Text] [Related]
7. The development of artificial endocrine pancreas. From bedside-, wearable-type to implantable one. Shichiri M; Kawamori R; Yamasaki Y Med Prog Technol; 1987; 12(1-2):39-50. PubMed ID: 3627019 [TBL] [Abstract][Full Text] [Related]
8. An artificial endocrine pancreas--problems awaiting solution for long-term clinical applications of a glucose sensor. Shichiri M; Fukushima H; Sakakida M; Kajiwara K; Hashiguchi Y Front Med Biol Eng; 1991; 3(4):283-92. PubMed ID: 1799562 [TBL] [Abstract][Full Text] [Related]
9. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas. Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126 [TBL] [Abstract][Full Text] [Related]
10. Modelling the glucose-insulin system as a basis for the artificial beta cell. Fischer U; Salzsieder E; Jutzi E; Albrecht G; Freyse EJ Biomed Biochim Acta; 1984; 43(5):597-605. PubMed ID: 6383364 [TBL] [Abstract][Full Text] [Related]
11. Wearable artificial endocrine pancrease with needle-type glucose sensor. Shichiri M; Kawamori R; Yamasaki Y; Hakui N; Abe H Lancet; 1982 Nov; 2(8308):1129-31. PubMed ID: 6128452 [TBL] [Abstract][Full Text] [Related]
12. No apparent local effect of insulin on microdialysis continuous glucose- monitoring measurements. Hermanides J; Wentholt IM; Hart AA; Hoekstra JB; DeVries JH Diabetes Care; 2008 Jun; 31(6):1120-2. PubMed ID: 18332157 [TBL] [Abstract][Full Text] [Related]
13. [Design and development strategy for wearable and implantable artificial endocrine pancreas]. Shichiri M; Nishida K Nihon Rinsho; 1999 Mar; 57(3):719-25. PubMed ID: 10199159 [TBL] [Abstract][Full Text] [Related]
14. The development of a needle-type glucose sensor for wearable artificial endocrine pancreas. Yamasaki Y Med J Osaka Univ; 1984 Sep; 35(1-2):25-34. PubMed ID: 6527668 [No Abstract] [Full Text] [Related]
15. [Development of wearable artificial endocrine pancreas--problems awaiting solutions for long-term clinical application]. Shichiri M Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1253-7. PubMed ID: 1944199 [TBL] [Abstract][Full Text] [Related]
16. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459 [TBL] [Abstract][Full Text] [Related]
17. A semi-closed loop computer-assisted insulin infusion system. Hospital use for control of diabetes in patients. Chisholm DJ; Kraegen EW; Bell DJ; Chipps DR Med J Aust; 1984 Dec 8-22; 141(12-13):784-9. PubMed ID: 6503781 [TBL] [Abstract][Full Text] [Related]
18. The development of an artificial beta cell system and its validation in depancreatized dogs: the physiological restoration of blood glucose homeostasis. Goriya Y; Kawamori R; Shichiri M; Abe H Med Prog Technol; 1979 Jun; 6(3):99-108. PubMed ID: 481366 [TBL] [Abstract][Full Text] [Related]